Based on the bioinformatics discoveries of PCOS and pan-cancer, our conclusion is that TOMM40 could potentially function as a potential -biomarker for the prediction and diagnosis of both PCOS and pan-cancer. This evidence concerns the gene TOMM40 and polycystic ovary syndrome.